Tag: Jeffrey Dayno

Jeffrey Dayno, CEO of Harmony Biosciences Holdings.

Plymouth Meeting-based Harmony Biosciences Acquires Epygenix Therapeutics, Adds Potential Epilepsy Treatment to Pipeline

May 3, 2024

Plymouth Meeting-based Harmony Biosciences acquired Epygenix Therapeutics of Paramus, New Jersey, last month, which added a potential treatment for epilepsy to its new drug…

Pharma & Biotech

Plymouth Meeting-based Harmony Biosciences Enters Exclusive Licensing Deal for Potential New Narcolepsy Therapy

April 18, 2024

Harmony Biosciences, a Plymouth Meeting-based pharmaceutical company, has entered into an exclusive licensing deal for the rights to develop and commercialize a new potential…

Pharma & Biotech

Plymouth Meeting’s Harmony Biosciences Holdings Acquires Zynerba Pharmaceuticals

August 15, 2023

Harmony Biosciences Holdings in Plymouth Meeting has agreed to buy Zynerba Pharmaceuticals for up to $200 million, writes John George for Philadelphia Business Journal.

Under…